Earnings ·
Ashland reports Q4 loss of $0.36 per share and issues FY27 sales outlook of $1.9B-$2.0B
ASHAshland Inc.
Ashland Inc. reported a preliminary fourth-quarter fiscal 2026 net loss of $16 million, or ($0.36) per diluted share, compared to a net income of $32 million in the prior-year quarter. Fourth-quarter sales rose four percent to $498 million, driven by volume growth in Life Sciences and Personal Care, while Adjusted EBITDA increased two percent to $121 million. The company also issued its full-year fiscal 2027 outlook, projecting sales of $1,905 million to $1,975 million and Adjusted EBITDA of $405 million to $435 million. Ashland Inc. is a global additives and specialty ingredients company serving markets including pharmaceuticals, personal care, and architectural coatings.